EP on EP Episode 64 - Myocardial Fibrosis and SCD Risk in Cardiomyopathy-EP on EP Episode 64_ Myocardial Fibrosis and SCD Risk in Cardiomyopathy

EP on EP Episode 64_ Myocardial Fibrosis and SCD Risk in Cardiomyopathy

Video Transcription

Video Summary

In this episode of "EP on EP," Eric Prostowski interviews Dr. Ed Gerstenfeld to discuss the role of scar in the heart in selecting patients for defibrillators. They analyze the case of a 42-year-old man with non-ischemic dilated cardiomyopathy, negative delayed enhancement on cardiac magnetic resonance imaging (CMR), and an ejection fraction (EF) of 30%. Dr. Gerstenfeld explains that while there is a mortality benefit to implantable defibrillators, it is important to consider the potential downsides, such as the risk of unnecessary shocks and infections. They discuss the controversy surrounding the presence of scar in non-ischemic cardiomyopathies and its impact on risk stratification. Dr. Gerstenfeld emphasizes the importance of shared decision-making with patients and continuous monitoring, as well as the use of CMR and genetics in risk assessment. Ultimately, the decision to implant an ICD in this patient depends on various factors, such as age, symptoms, comorbidities, and patient preferences.

Keywords

EP on EP

Eric Prostowski

Dr. Ed Gerstenfeld

scar in the heart

defibrillators